Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2017, Article ID 1781087, 7 pages
https://doi.org/10.1155/2017/1781087
Research Article

Single-Centre Experience of Systemic Treatment with Vincristine, Ifosfamide, and Doxorubicin Alternating with Etoposide, Ifosfamide, and Cisplatin in Adult Patients with Ewing Sarcoma

1Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
2Department of Pathology, University Hospitals Leuven, Leuven, Belgium
3Department of Oncology, KU Leuven and University Hospitals Leuven, Leuven, Belgium
4Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium

Correspondence should be addressed to Annelies Requilé; moc.liamg@eliuqerseilenna

Received 30 July 2017; Revised 29 October 2017; Accepted 6 November 2017; Published 28 December 2017

Academic Editor: U. Dirksen

Copyright © 2017 Annelies Requilé et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Annelies Requilé, Paul M. Clement, Oliver E. Bechter, et al., “Single-Centre Experience of Systemic Treatment with Vincristine, Ifosfamide, and Doxorubicin Alternating with Etoposide, Ifosfamide, and Cisplatin in Adult Patients with Ewing Sarcoma,” Sarcoma, vol. 2017, Article ID 1781087, 7 pages, 2017. https://doi.org/10.1155/2017/1781087.